Sunshine Biopharma

(NASDAQ) SBFMW

Current Price$0.05

Market CapN/A

Since IPO (2022)-90%

5 YearN/A

1 Year-79%

1 Month-56%

Sunshine Biopharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$35.49M

Net Income (TTM)

-$6.04M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$0.05

Volume

13,280

Open

$0.08

Price

$0.05

Volume

13,280

Open

$0.08

Previous Close

$0.06

Daily Range

$0.06 - $0.09

52-Week Range

$0.03 - $0.65

Estimated Earnings Date

Aug 5, 2026

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$0.05

Volume

13,280

Open

$0.08

Previous Close

$0.06

Daily Range

$0.06 - $0.09

52-Week Range

$0.03 - $0.65

Estimated Earnings Date

Aug 5, 2026

SBFMW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sunshine Biopharma

Industry

Biotechnology

Sector

Health Care

Headquarters

Pointe-Claire, QC H9R 0A5, CA

SBFMW Financials

Key Financial Metrics (TTM)

Gross Margin

32.49%

Operating Margin

-12.90%

Net Income Margin

-17.01%

Return on Equity

-25.58%

Return on Capital

-18.78%

Return on Assets

-21.62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

13.28K

Avg. Volume

13.76K

Financials (TTM)

Gross Profit

$11.53M

Operating Income

-$4.58M

EBITDA

-$5.63M

Operating Cash Flow

-$5.69M

Capital Expenditure

$180.78K

Free Cash Flow

-$5.51M

Cash & ST Invst.

$6.91M

Total Debt

$744.84K

Sunshine Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$8.09M

-9.1%

Gross Profit

$2.10M

-22.9%

Gross Margin

26.01%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.24M

-5.4%

EBITDA

-$1.17M

-1.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$6.91M

-15.6%

Total Debt

$744.84K

-20.4%

Accounts Receivable

$4.01M

+16.4%

Inventory

$13.17M

+11.1%

Long Term Debt

$535.61K

-25.8%

Short Term Debt

$209.23K

-2.2%

Return on Assets

-21.62%

N/A

Return on Invested Capital

-20.76%

N/A

Free Cash Flow

-$2.08M

-8.9%

Operating Cash Flow

-$2.07M

-22.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BFRIBiofrontera Inc.

BFRIBiofrontera Inc.$0.97+2.58%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$4.97+9.23%

IINNInspira Technologies Oxy B.H.N. Ltd.

IINNInspira Technologies Oxy B.H.N. Ltd.$2.01+5.79%

LFWDLifeward Ltd.

LFWDLifeward Ltd.$7.20+4.80%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.36+0.00%

LYRALyra Therapeutics, Inc.

LYRALyra Therapeutics, Inc.$0.44-11.98%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.55-0.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

Questions About SBFMW

What is the current price of Sunshine Biopharma?

Sunshine Biopharma is trading at $0.06 per share.

What is the 52-week range for Sunshine Biopharma?

Over the past 52 weeks, Sunshine Biopharma has traded between $0.03 and $0.65.

How much debt does Sunshine Biopharma have?

Sunshine Biopharma total debt is unavailable.

How much cash does Sunshine Biopharma have on hand?

Sunshine Biopharma does not have cash on hand data available.

What is Sunshine Biopharma’s dividend yield?

Sunshine Biopharma does not currently have a dividend yield.

Sunshine Biopharma

Sunshine Biopharma Financials at a Glance

SBFMW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sunshine Biopharma

SBFMW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sunshine Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SBFMW

What is the current price of Sunshine Biopharma?

What is the 52-week range for Sunshine Biopharma?

How much debt does Sunshine Biopharma have?

How much cash does Sunshine Biopharma have on hand?

What is Sunshine Biopharma’s dividend yield?

Premium Investing Services